Delivery Order SPE2DB22D3301-SPE2DB25FX8FF

Award Date 1/9/25
Potential Completion Date 1/10/25
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,674.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,508,407 tablets of Citalopram HBR 40 mg, a common antidepressant medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical. This IDC...
This federal contract award, valued at $15,913.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4566419679 citalopram HBR 40 mg tablets in 500-count bottles. It is a firm-fixed-price delivery order contract with a completion date of November 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award is for the delivery of 4,560,392 units of Citalopram HBr 40 mg tablets, a generic antidepressant medication, to the Defense Logistics Agency (DLA). The $3,433.00 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 27, 2023, with a performance period through March 28, 2023. This appears to be a discrete delivery order placed against an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,383.50 firm fixed-price delivery order contract is for the supply of 4,561,682,655 units of Citalopram HBR 40 mg tablets, a medication used to treat depression. The contract has an ultimate completion date of August 3, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a $4,357.57 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for 4,565,423,516 tablets of 40mg Citalopram HBR, an antidepressant medication. The contract has a firm fixed price and an ultimate completion date of August 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, that enables the agency to efficiently...
This federal contract award, valued at $2,262.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under the existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, which has a ceiling value of $999,999,999 and runs through November 2026. The contract is for the delivery of 4,566,619,263 units of Citalopram HBR 40mg tablets, a generic antidepressant medication. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,631.86 firm-fixed-price delivery order is for the supply of 4,561,312,585 units of Citalopram HBR 40 mg tablets, a medication used to treat depression. The contract has a period of performance through June 22, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,560.28 delivery order contract is for the supply of 4,563,906,134 tablets of Citalopram HBR 40 mg, a generic medication used to treat depression. The contract has an ultimate completion date of March 11, 2024 and is a firm fixed-price arrangement. Amerisourcebergen holds a larger $999,999,999 Indefinite...
This federal contract award, valued at $1,129.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,564,222,913 units of Citalopram HBR 40 mg tablets, with an ultimate completion date of April 10, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order valued at $1,599.92 to supply 4,564,996,782 units of the prescription medication Citalopram Hydrobromide 40 mg tablets, which are used to treat depression. The contract does not have a set-aside designation and is a Firm Fixed Price arrangement. Amerisourcebergen's Corporate Office Division is the prime...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX8FF
    Delivery Order

This federal contract award, valued at $6,231.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,883,578 units of Citalopram HBR 40 mg Tablets, a generic medication used to treat depression. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a firm fixed price and an ultimate completion date of January 10, 2025. The contract was not designated as a set-aside.

Generated 4/10/25, 11:29 AM